Cinctive Capital Management Portfolio holdings
Top Buys
Top Sells
| 1 |
CTLT
CATALENT, INC.
CTLT
|
+$13.1M |
| 2 |
Eli Lilly
LLY
|
+$12.3M |
| 3 |
A.O. Smith
AOS
|
+$10.6M |
| 4 |
HMCOU
HumanCo Acquisition Corp. Unit
HMCOU
|
+$9.96M |
| 5 |
Avantor
AVTR
|
+$9.86M |
Sector Composition
| 1 | Technology | 23.76% |
| 2 | Healthcare | 16.84% |
| 3 | Consumer Discretionary | 13.13% |
| 4 | Industrials | 10.75% |
| 5 | Financials | 5.5% |
Similar funds
Cinctive Capital Management's Q1 2021 Portfolio in Review
As of Q1 2021, Cinctive Capital Management held 550 positions worth $1.63B, up 33% from $1.23B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Cinctive Capital Management deployed $337M of net new capital in Q1 2021, opening 234 new positions and adding to 73 existing holdings. Its largest new stake was Boston Scientific: 406,374 shares worth $15.7M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 13% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Avantor, an estimated $9.86M trimmed.
- Cinctive Capital Management's largest Q1 2021 buy was Boston Scientific: 406,374 shares worth $15.7M.
- Cinctive Capital Management added most to Meta Platforms (Facebook) in Q1 2021, an estimated $15.9M increase.
- Cinctive Capital Management's biggest Q1 2021 reduction was Avantor, cutting an estimated $9.86M.
- Cinctive Capital Management fully exited CATALENT, INC. in Q1 2021, selling an estimated $13.1M.
- Cinctive Capital Management's ten largest holdings make up 13% of its $1.63B portfolio in Q1 2021.
- Cinctive Capital Management opened 234 new positions and closed 151 in Q1 2021.
- Cinctive Capital Management's portfolio value rose 33% quarter-over-quarter to $1.63B.
Based on Cinctive Capital Management's 13F filing for Q1 2021, filed 17 May 2021.